ESAB
ESAB Corporation
ESAB's fundamentals are mixed, but it looks expensive: trading at 34x earnings, above its usual 26x. Analysts expect earnings growth.
ESAB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Weak |
ESAB's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.
ESAB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $82.55 | — |
| Cheap | 18x | $43.61 | -47% |
| Fair | 26x | $63.73 | -23% |
| Expensive | 29x | $71.57 | -13% |
| Current | 34x | $82.55 | — |
Historical ranges are pointers, not guarantees.
ESAB's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
ESAB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ESAB, with profitability holding steady.
ESAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.91 | +142% |
| Q3 2026 | $2.44 | -38% |
| Q2 2026 | $2.76 | -34% |
| Q1 2026 | $3.35 | -24% |
| Q4 2025 | $3.67 | -15% |
| Q3 2025 | $3.96 | -7.3% |
| Q2 2025 | $4.17 | +1.7% |
| Q1 2025 | $4.43 | +16% |
| Q4 2024 | $4.31 | +28% |
ESAB's earnings per share have fallen from their peak: $2.44 over the past year, against $4.43 in early 2025.
ESAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $824.5M | +13% |
| Q2 2026 | $807.6M | +13% |
| Q1 2026 | $745.6M | +9.9% |
| Q4 2025 | $721M | +7.5% |
| Q3 2025 | $727.8M | +8.1% |
| Q2 2025 | $715.6M | +1.2% |
| Q1 2025 | $678.1M | -1.7% |
| Q4 2024 | $670.8M | -2.7% |
ESAB's revenue has grown year over year for six quarters in a row: $825M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -3.5 points |
| Q2 2026 | 9.8% | -5.5 points |
| Q1 2026 | 12% | -4.1 points |
| Q4 2025 | 12% | -4.6 points |
| Q3 2025 | 15% | -1.1 points |
| Q2 2025 | 15% | -1.6 points |
| Q1 2025 | 16% | +0.2 points |
| Q4 2024 | 17% | +1.6 points |
ESAB's operating margin was 11% last quarter, down 3.5 points from the same quarter a year ago, near the bottom of its range since 2021.
ESAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $54.4M | -23% |
| Q2 2026 | $15.7M | -58% |
| Q1 2026 | $33.2M | +18% |
| Q4 2025 | $77.4M | -24% |
| Q3 2025 | $70.3M | -22% |
| Q2 2025 | $37.4M | -49% |
| Q1 2025 | $28.1M | -24% |
| Q4 2024 | $102.2M | -0.9% |
ESAB's free cash flow has been positive every quarter since early 2021: $181M over the past year, down 24% from the year before.
ESAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +763K shares |
| 1 year | +1.9% | +1.2M shares |
| 3 years | +2.7% | +1.7M shares |
| 5 years | +4% | +2.4M shares |
ESAB has 62M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
ESAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.7x | High |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 2.2x | Moderate |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.6x | Healthy |
ESAB's net debt is about 4.6 years of its operating earnings (EBITDA), up from 2.2 years a year ago.
ESAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 47.4 | Neutral |
ESAB's weekly RSI is 50 (neutral) and its Stochastic is 47 (neutral).
ESAB PE vs Industrials Sector
| Metric | ESAB | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 24x | 41% above |
| PE % | 97 | 68 | 29 pts above |
ESAB is trading at 34x earnings, a 41% premium to the Industrials sector's median of 24x.
ESAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.0 | 15% above |
| 20 week MA | $78.2 | 5.6% above |
| 50 week MA | $96.0 | 14% below |
| 100 week MA | $107.8 | 23% below |
| 200 week MA | $96.5 | 14% below |
ESAB has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 14% below its 200-week average.
ESAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $50.0 | $49.1 | -1.8% |
| 2023 | $49.1 | $86.6 | +76% |
| 2024 | $86.6 | $121.4 | +40% |
| 2025 | $121.4 | $114.2 | -5.9% |
| 2026 YTD | $114.2 | $82.6 | -28% |
ESAB has finished lower in two of the last four years. It's down 28% so far in 2026.